US 8338418
Dual-acting antihypertensive agents
granted A61KA61K31/4196A61K45/06
Quick answer
US patent 8338418 (Dual-acting antihypertensive agents) held by Theravance, Inc. expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/4196, A61K45/06, A61P, A61P13/12